Prolonged Activation of the Htr2b Serotonin Receptor Impairs Glucose Stimulated Insulin Secretion and Mitochondrial

Luis Rodrigo Cataldo1, María L Mizgier1, Roberto Bravo Sagua2

  • 1Department of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Plos One
|January 28, 2017
PubMed
Abstract

Insights

Prolonged activation of serotonin receptor Htr2b in pancreatic beta cells reduces insulin secretion and mitochondrial function. This occurs through mechanisms involving increased PGC1α/PPARy expression, impacting glucose metabolism.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Pancreatic beta cells synthesize and release serotonin (5-hydroxytryptamine, 5HT).
  • The precise role of 5HT receptors in glucose-stimulated insulin secretion (GSIS) and their underlying mechanisms remain incompletely understood.

Purpose of the Study:

  • To determine the expression profile of 5HT receptors in murine MIN6 beta cells.
  • To investigate the effects of pharmacological activation of the 5HT receptor Htr2b on GSIS and mitochondrial function.

Main Methods:

  • Quantified 5HT receptor mRNA levels using RT-qPCR.
  • Assessed GSIS in MIN6 cells with 5HT and Htr2b modulation (BW723C86 or SB204741).
  • Evaluated PGC1α and PPARy expression and mitochondrial function (OCR, ATP content) following Htr2b activation.

Main Results:

  • Htr2b mRNA was detected in MIN6 cells, while other 5HT receptors were largely absent.
  • Activation of Htr2b with 5HT or BW723C86 reduced GSIS; this effect was blocked by SB204741.
  • Htr2b activation increased PGC1α and PPARy expression but decreased mitochondrial respiration and ATP levels.

Conclusions:

  • Prolonged Htr2b activation in murine beta cells impairs GSIS and mitochondrial activity.
  • These effects are likely mediated by enhanced PGC1α/PPARy expression.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.9K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.8K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.4K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K